IULS-University Institute for Locomotion and Sports, Hôpital Pasteur 2, University Côte d'Azur (UCA), Nice, France.
Clinique Chantecler, Marseille, France.
J Shoulder Elbow Surg. 2020 Oct;29(10):2111-2122. doi: 10.1016/j.jse.2020.02.008. Epub 2020 Jun 4.
Glenoid lateralization has been shown to be the most imortant factor in maximizing passive range of motion and shoulder stability while preventing scapular impingement and notching. We aimed to evaluate mid- to long-term functional and radiologic outcomes after bony increased-offset-reverse shoulder arthroplasty (BIO-RSA) using a Grammont-style (medialized) humeral implant.
The study included 143 consecutive shoulders (140 patients; mean age, 72 years) treated with a BIO-RSA for rotator cuff deficiency. A cylinder of autologous cancellous bone graft, harvested from the humeral head, was placed between the reamed glenoid surface and baseplate; fixation was achieved using a long central peg (25 mm) and 4 screws. A large baseplate (29 mm) with a small baseplate sphere (36 mm) was used in 77% of cases, and a Grammont-style (medialized) humeral implant with 155° of inclination was used in all cases. All patients underwent clinical and radiographic assessment at a minimum of 5 years after surgery; in addition, 86 cases (60%) underwent computed tomography scan assessment.
At a mean follow-up of 75 months (range, 60-126 months), the survivorship of the BIO-RSA using revision as an endpoint was 96%. No cases of dislocation or humeral loosening were observed. Overall, 118 patients (83%) were either very satisfied (61%) or satisfied (22%). The adjusted Constant score improved from 40% ± 18% to 93% ± 23%, and the Subjective Shoulder Value improved from 31% ± 15% to 77% ± 18% (P < .001). The humeral bone graft incorporated completely in 96% of cases (137 of 143). Severe inferior scapular notching (grade 3 or 4) occurred in 18% (24 of 136). The risk of postoperative notching correlated to a lower body mass index (P < .05), superior glenosphere inclination (P = .02), and high or flush glenosphere positioning (P = .035).
BIO-RSA is a safe and effective technique to lateralize the glenoid, providing consistent bone graft healing, excellent functional outcomes, a low revision rate, and a high rate of patient satisfaction. Thin patients (with a low body mass index) and glenosphere malposition (with persistent superior inclination and/or insufficient lowering of the baseplate and sphere) are associated with higher risk of scapular notching.Our data confirm the importance of implanting the baseplate with a neutral inclination (reverse shoulder arthroplasty angle < 5°) and with sufficient glenosphere inferior overhang (>5 mm) in preventing scapular notching. The use of a less medialized humeral implant (135° or 145° inclined) and smaller (25-mm) baseplate (when using a small, 36-mm sphere) should allow reduction in the incidence of scapular notching.
在预防肩胛带撞击和肩胛切迹的同时,最大限度地提高被动活动范围和肩部稳定性,肩胛盂的外侧化是最重要的因素。我们旨在评估使用 Grammont 式(内侧化)肱骨头假体的骨质增加偏移式反肩关节置换术(BIO-RSA)的中期至长期功能和影像学结果。
这项研究纳入了 143 例连续接受 BIO-RSA 治疗的肩袖缺损患者(140 例患者;平均年龄 72 岁)。从肱骨头中取出的自体松质骨圆柱被置于研磨后的肩胛盂表面和基底之间;使用长中央钉(25mm)和 4 颗螺钉进行固定。77%的病例使用大基底(29mm)和小基底球(36mm),所有病例均使用 155°倾斜的 Grammont 式(内侧化)肱骨头假体。所有患者在术后至少 5 年进行临床和影像学评估;此外,86 例(60%)进行了计算机断层扫描评估。
平均随访 75 个月(范围 60-126 个月),以翻修为终点的 BIO-RSA 生存率为 96%。未观察到脱位或肱骨头松动。总体而言,118 例(83%)患者非常满意(61%)或满意(22%)。调整后的 Constant 评分从 40%±18%提高到 93%±23%,主观肩部评分从 31%±15%提高到 77%±18%(P<.001)。96%(143 例中有 137 例)的肱骨骨移植物完全融合。严重的肩胛下切迹(3 级或 4 级)发生率为 18%(136 例中有 24 例)。术后切迹的风险与较低的体重指数(P<.05)、较高的上关节盂倾斜度(P=0.02)和较高或平齐的关节盂位置(P=0.035)相关。
BIO-RSA 是一种安全有效的外侧化肩胛盂技术,可实现一致的骨移植物愈合,提供出色的功能结果、低翻修率和高患者满意度。体型较瘦(体重指数较低)和关节盂位置不当(持续存在上关节盂倾斜和/或基底和球不足)与较高的肩胛带切迹风险相关。我们的数据证实了植入具有中性倾斜度(反向肩关节置换角度<5°)和足够关节盂下悬垂度(>5mm)的基底以预防肩胛带切迹的重要性。使用较小的(25mm)基底(当使用较小的 36mm 球时)和较小的(135°或 145°倾斜)肱骨头假体,可以降低肩胛带切迹的发生率。